30 closest matches · ranked by relevance
Pregnancy, High Risk · Opioid-Related Disorders · Pregnancy Related
Primary: Opioid Use Disorder (OUD) and Other Substance Use Disorder (SUD) Treatment Linkage/Retention — -1.5; -8.8 Percentage of days
Opioid-use Disorder
Primary: Treatment Engagement — 78; 64; 109; 92 Participants — p=0.5340
Opioid Use Disorders
Primary: Cravings — 11.90; 8.94; 11.10; 8.21 score on a scale (total score, 0 to 30) — p=0.12
Opioid Use Disorder · Pregnancy Related · Substance Use
Primary: Medication for Opioid Use Disorder (MOUD) Knowledge Score — 83.5; 72.0 percentage of correct answers
Opioid-use Disorder
Primary: Number of Participants Who Self-reported Retention in Medication Treatment for Opioid Use Disorder — 2 participants who reported 'yes' to MOUD
Contraception
Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants
Maternal Opioid Use Disorder · Opioid Exposed Infant
Primary: Fetal Heart Rate at 24 Weeks — 143.64 beats per minute
Opioid Related Disorders · Pregnancy · Opioid Dependence
Primary: Child's Head Circumference Measurement (Measured at Birth) — 33.0; 33.8 cm
Opioid Use · Postpartum Disorder · Chronic Pain Syndrome
Primary: Time to Opioid Cessation as a Measure of Opioid Utilization — 2; 2 weeks
Surgery · Opioid Use
Primary: Unused Opioids — 5; 10 oxycodone 5mg tablets
Neonatal Abstinence Syndrome
Primary: Percent of Infants Diagnosed With Neonatal Abstinence Syndrome (NAS) Requiring Medication Treatment — 24.1; 33.3 % infants requiring medication for NAS
Post-Cesarean Pain · Cesarean Section Complications
Primary: Mean Pain Score — 4.1; 4.2; 5.1; 5.2 score on a scale
Neonatal Abstinence Syndrome · Neonatal Opiate Withdrawal Syndrome
Primary: Buprenorphine Pharmacokinetics
Opioid Use Disorder
Primary: Opioid Craving — 21.6; 22.4; 23.3; 23.4 score on a scale
Neonatal Abstinence Syndrome
Primary: Fetal Heart Rate — 145.7; 143.3; 138.6; 136.3 beats per minute — p=0.001
Opioid-use Disorder
Primary: Adherence to Medication Assisted Treatment (MAT) — 32; 17 Participants
Opioid Use
Primary: Opioid Use — 7.5; 10 hydrocodone tablets
Neonatal Abstinence Syndrome
Primary: Length of Hospital Stay — 17.9; 16.1 days
Parenting · Opioid-use Disorder · Father-Child Relations
Primary: Parenting Practices Interview — 2.84; 3.83 score on a scale — p=<0.001
Pregnancy · Drug Abuse
Primary: Fetal Heart Rate — 142.34 beats per minute
Narcotic Addiction · Neonatal Abstinence Syndrome
Primary: Number of Participants With Neonatal Abstinence Syndrome — 22; 26 Participants — p=0.2
Opioid-use Disorder
Primary: Treatment Success Rate — 70; 67 Participants — p=0.7326
Pregnancy Related
Primary: Feasibility of the Intervention — 21.5; 21.2 score on a scale
Pain
Primary: Total Opioid Intake in Morphine Milligram Equivalents in the First 48 Hours After Cesarean Delivery (CD) — 42; 49.5 morphine milligram equivalents
Opioid Medication Assisted Treatment
Primary: Number of Patients Within Participating Sites With OUD Initiating MOUD During the Implementation Facilitation Period in Implementation Sites. This Will be Compared to…
Opioid-use Disorder · Mental Disorder · Opioid Medication Assisted Treatment
Primary: Number of Participants With Self-reported Treatment Retention — 51 Participants
Contraceptive Usage · Opioid Dependence
Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001
Opioid-use Disorder
Primary: Intervention PCP Confidence in Assessing and Treating OUD — 6; 11; 8; 1 Participants
Opioid-use Disorder
Primary: Urine Drug Screening Test Results — 92.3; 92.0; 1.9; 2.0 percentage of participants positive
Hepatitis C, Chronic · Opioid-use Disorder
Primary: Number of Participants Initiating in Hepatitis C Virus (HCV) Treatment — 21 Participants